University Hospital Heidelberg-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2023

  1. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

    Acta Neuropathologica, Vol. 145, Núm. 5, pp. 651-666

2013

  1. High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas

    Genes Chromosomes and Cancer, Vol. 52, Núm. 2, pp. 150-155